Concepedia

Joë-Marc Chauvin

JC

Statistics

Publications

15

Citations

3.6K

H-Index

15

Active since

2009

Affiliations

University of Pittsburgh(Current)

UPMC Hillman Cancer Center

Inserm

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (United States)

Joë-Marc Chauvin is an author at University of Pittsburgh specializing in immunology, cancer immunotherapy, and oncology.

ORCID

Publications per year

2009–2024

15

Publications

15

Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

Diwakar Davar, Amiran Dzutsev, John A. McCulloch et al. · Science · 2021 · 1.6K citations · Full text

, , +17

TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients

Joë-Marc Chauvin, Ornella Pagliano, Julien Fourcade et al. · Journal of Clinical Investigation · 2015 · 769 citations · Full text

, , +17

PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen–Specific CD8+ T Cells Induced by Melanoma Vaccines

Julien Fourcade, Zhaojun Sun, Ornella Pagliano et al. · Cancer Research · 2013 · 205 citations · Full text

, , +17

CD226 opposes TIGIT to disrupt Tregs in melanoma

Julien Fourcade, Zhaojun Sun, Joë-Marc Chauvin et al. · JCI Insight · 2018 · 200 citations · Full text

, , +17

IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells

Zhaojun Sun, Julien Fourcade, Ornella Pagliano et al. · Cancer Research · 2015 · 194 citations

, , +17

1–5 of 15